Milestones in the development of VPCIR
STEP 1
Basic research Aarhus University (AU), Aarhus University Hospital and
Chinese University of Hong Kong (CUHK) on restriction enzymes
STEP 2
Proof of concept in testing for E. coli using restriction enzyme patterns
STEP 3
Establishment of VPCIR biosciences aps
STEP 4
Submission of VPCIR patent application by AU/CUHK
STEP 5
Grant at DKK 1.5M
from Innovation Fund Denmark
STEP 6
Development of first-generation assay (Listeria) commences
STEP 7
Grant at DKK 0.9 M from Novo Nordisk Foundation
STEP 8
Exclusive license agreement between VPCIR and AU/CUHK on use of patent
STEP 9
Investment by a group of Danish business angels at DKK 1.7 M
STEP 10
EU Commission grants Seal of Excellence to VPCIR biosciences aps
STEP 11
The group of dedicated business angels, organized in VPCIR Invest ApS decides to increase their commitment and investment level in VPCIR
STEP 13
VPCIR has successfully negotiated a €134.000 loan arrangement with the Danish Vaekstfonden
STEP 14
VPCIR biosciences have obtained European trademark protection for our disruptive VPCIR technology. We expect to launch the first VPCIR™ products in about 6 months time
STEP 15
VPCIR biosciences launches a webshop offering its first commercial product:
A human topoisomerase 1 (hTOP1) enzyme for laboratory use available now.
New event 12
Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna suprecent.
Our partners
